Veterinary News

DALLAS--(BUSINESS WIRE)--Evette, today’s leading nationwide veterinary relief staffing agency, announced the expansion of its leadership team, naming Dr. Eric Mueller, DVM, as Vice President of Clinical Operations. The appointment of Evette’s first-ever internal DVM comes as the company continues on a path of rapid growth and innovation in the veterinary industry, and reinforces its commitment to amplifying veterinarian voices. Dr. Eric Mueller comes to Evette with over a decade of wide-ranging...

PLANTATION, Fla.--(BUSINESS WIRE)--Chewy, Inc. (NYSE: CHWY) (“Chewy”), a trusted destination for pet parents and partners everywhere, has released its financial results for the fiscal fourth quarter and full year 2024 ended February 2, 2025. Fiscal Q4 2024 Results (1): Net sales of $3.25 billion improved 14.9 percent year over year Gross margin of 28.5 percent expanded 30 basis points year over year Net income of $22.8 million, including share-based compensation expense and related taxes of $99...

DUBLIN--(BUSINESS WIRE)--The "A Practical Approach to Developing the CMC Package for Veterinary Pharmaceutical Products Training Course" has been added to ResearchAndMarkets.com's offering. Understanding the chemistry, manufacturing and controls (CMC) requirements for veterinary pharmaceuticals is essential to support successful registration in the EU Regulations for CMC of veterinary pharmaceuticals are complex and are regularly updated, making pharmaceutical product development challenging. I...

NEW YORK--(BUSINESS WIRE)--OS Therapies (NYSE-A: OSTX) (“OS Therapies” or “the Company”), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today announced that OST-HER2 is featured in the upcoming movie Shelter Me: The Cancer Pioneers. The movie offers a look into canine comparative oncology, a field that compares treatment of cancers in dogs to those in people, and covers developing treatments for rare forms of cancer. OST-HER2 is an immunotherapy for...

NEW YORK--(BUSINESS WIRE)--The Board of Directors of Colgate-Palmolive Company (NYSE:CL) today increased the quarterly common stock cash dividend to $.52 up from $.50 per share. The increase will be effective in the second quarter, 2025. The Board declared that the second quarter dividend is to be paid on May 15, 2025 to shareholders of record as of April 17, 2025. On an annual basis, the new dividend rate is $2.08 vs. $2.00 per share previously. The Company has paid uninterrupted dividends on...

BERWYN, Penn.--(BUSINESS WIRE)--Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (“Virpax” or the “Company”), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and anti-viral barrier indications, today announced positive results from a beagle dog dose range finding (“DRF”) study. Probudur is the company’s long-acting liposomal bupivacaine formulation injected at a wound site to provide both immediat...

AUSTIN, Texas--(BUSINESS WIRE)--VMD Sciences, the global leader in veterinary regulatory pharmaceutical services, played a pivotal role in helping a community veterinarian access an experimental treatment for a dog whose life-threatening soft tissue sarcoma was deemed inoperable. This success story highlights the potential of utilizing legislated regulatory pathways in veterinary medicine, a burgeoning field that offers hope for animals with serious health conditions where no other options are...

FOUNTAIN VALLEY, Calif.--(BUSINESS WIRE)--Wisdom Panel™, the world's leading pet DNA service, has reached a milestone in its 20+ year history: 5 million pets’ DNA tested. For decades, Wisdom Panel has helped pet parents understand their pet's unique story—one test at a time—strengthening the bond they share. To celebrate 5 million pets tested, the company surveyed over 10,000 pet parents to uncover the heartwarming (and often hilarious) ways that bond plays out in everyday life. This deep conne...

NEW YORK--(BUSINESS WIRE)--Christie Horvath, CEO and founder of Wagmo, has been named to the eighth annual Female Founders list by Inc....

LOVELAND, Colo.--(BUSINESS WIRE)--Antech, a global veterinary diagnostics, technology and imaging company, today announced the launch of trūRapid™ FOUR, a comprehensive in-house canine vector-borne disease (CVBD) screening test. trūRapid™ FOUR is a lateral flow test used to detect canine antibodies to Anaplasma spp., Ehrlichia spp., and Lyme C6 (Borrelia burgdorferi), as well as heartworm (Dirofilaria immitis) antigen, using whole blood, serum, or plasma. Jimmy Barr, DVM, DACVECC, Chief Medical...